bioMérieux SA (BMXMF)
OTC
Closed
Aug 24, 2026
Day's Range
80.6652 wk Range
77.00Overview - BMXMF - bioMérieux SA
Key Statistics
Valuation
Enterprise Value
11.15B
P/E (Trailing)
18.27
Price / Sales (TTM)
2.45
Price / Book
1.95
EV / EBITDA
9.09
Profitability
Profit Margin
11.59%
Operating Margin
15.23%
Return on Assets
7.23%
Return on Equity
11.22%
Ownership
Shares Outstanding
117.98M
Float
40.02M
Held by Insiders
66.46%
Held by Institutions
16.76%
Price stats
Beta
0.57
50-Day Avg
79.88
200-Day Avg
103.06
Dividends
Payout Ratio
25.12%
Frequency
Annual
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - BMXMF - bioMérieux SA
Peer Comparison
Compared with companies in Diagnostics & Research listed on OTC.
Profile Summary - BMXMF - bioMérieux SA
About
bioMérieux SA is a family-owned French company and a world leader in the field of in vitro diagnostics, founded in 1963 by the Mérieux family. It pioneers, develops, and produces high-quality diagnostic solutions to improve public health worldwide, with a core purpose of making the world a healthier place through…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
